Unknown

Dataset Information

0

A smart multiantenna gene theranostic system based on the programmed assembly of hypoxia-related siRNAs.


ABSTRACT: The systemic therapeutic utilisation of RNA interference (RNAi) is limited by the non-specific off-target effects, which can have severe adverse impacts in clinical applications. The accurate use of RNAi requires tumour-specific on-demand conditional activation to eliminate the off-target effects of RNAi, for which conventional RNAi systems cannot be used. Herein, a tumourous biomarker-activated RNAi platform is achieved through the careful design of RNAi prodrugs in extracellular vesicles (EVs) with cancer-specific recognition/activation features. These RNAi prodrugs are assembled by splitting and reconstituting the principal siRNAs into a hybridisation chain reaction (HCR) amplification machine. EVs facilitate the specific and efficient internalisation of RNAi prodrugs into target tumour cells, where endogenous microRNAs (miRNAs) promote immediate and autonomous HCR-amplified RNAi activation to simultaneously silence multiantenna hypoxia-related genes. With multiple guaranteed cancer recognition and synergistic therapy features, the miRNA-initiated HCR-promoted RNAi cascade holds great promise for personalised theranostics that enable reliable diagnosis and programmable on-demand therapy.

SUBMITTER: Gong X 

PROVIDER: S-EPMC8233311 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4145614 | biostudies-literature
| S-EPMC7734702 | biostudies-literature
| S-EPMC10323617 | biostudies-literature
| S-EPMC9277110 | biostudies-literature
| S-EPMC4166430 | biostudies-other
| S-EPMC5706105 | biostudies-literature
| S-EPMC10826438 | biostudies-literature
| S-EPMC6019194 | biostudies-literature
| S-EPMC6933523 | biostudies-literature
| S-EPMC4232585 | biostudies-literature